The US FDA conducted plant inspection in the third week of April 2015
SMS Pharmaceuticals has received approval from the US FDA for its Andhra Pradesh-based manufacturing facility for its manufacturing facility located at Kandivalasa village in Vizianagaram district of Andhra Pradesh, SMS Pharmaceuticals said in a regulatory filing.
The USFDA had conducted inspection of the plant in the third week of April 2015, it added.
SMS Pharmaceuticals is engaged in manufacturing of active pharmaceutical ingredients (API) and currently has four production facilities and two research centers in operation.
- Advertisement -
Comments are closed.